AMD and DME Treatment Innovations: Home Monitoring, Artificial Intelligence Diagnostics and Extended Duration Anti-VEGF Therapeutics
Chairperson(s): A. Loewenstein ISREAL
Speakers and presentations:
A. Loewenstein ISREAL
14:00 Welcome, ARS & review of EURETINA AMD & DME clinical trends survey data
S. Wolf SWITZERLAND
14:05 The Anti-VEGF treatment burden
R. Tadayoni FRANCE
14:13 Current and future applications of longer lasting Anti-VEGF therapeutics
C. Awh USA
14:21 Insights and pearls on implantable sustained release technologies
A. Loewenstein ISREAL
14:29 Artificial Intelligence (AI) in nAMD & DME treatment decision-making
A. Loewenstein ISREAL
14:37 Final ARS, live Q&A and panel discussion
14:45 Session Ends
